【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Myocardial Ischemia Overview 8
Therapeutics Development 9
Pipeline Products for Myocardial Ischemia – Overview 9
Pipeline Products for Myocardial Ischemia – Comparative Analysis 10
Myocardial Ischemia – Therapeutics under Development by Companies 11
Myocardial Ischemia – Therapeutics under Investigation by Universities/Institutes 12
Myocardial Ischemia – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Myocardial Ischemia – Products under Development by Companies 16
Myocardial Ischemia – Products under Investigation by Universities/Institutes 18
Myocardial Ischemia – Companies Involved in Therapeutics Development 19
Baxter International Inc. 19
CoDa Therapeutics, Inc. 20
Lixte Biotechnology Holdings, Inc. 21
Miltenyi Biotec GmbH 22
Nyken BV 23
Opsona Therapeutics Ltd. 24
Taxus Cardium Pharmaceuticals Group Inc. 25
ViroMed Co., Ltd. 26
Myocardial Ischemia – Therapeutics Assessment 27
Assessment by Monotherapy Products 27
Assessment by Target 28
Assessment by Mechanism of Action 30
Assessment by Route of Administration 32
Assessment by Molecule Type 34
Drug Profiles 36
alferminogene tadenovec – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
AntimiR-199a – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
EP-80317 – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Gene Therapy for Ischemic Heart Failure – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Humanin – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
LB-100 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
LB-102 – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
MG-53 – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
NYK-1112 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
OPN-305 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Peptagon – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
PMC-6 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Protein for Myocardial Infarction and Critical Limb Ischemia – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Recombinant Peptide to Activate FPR2 for Ischemia Reperfusion Injury and Myocardial Ischaemia – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
Recombinant Protein to Inhibit CXCL for Cardiovascular and Immunology – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Small Molecule to Inhibit Arginase-1 and Arginase-2 for Myocardial Ischemia and Ischemia Reperfusion Injury – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Small Molecules to Activate Heat Shock Protein H11 Kinase for Myocardial Ischemia – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Small Molecules to Antagonize TRPM7 for Myocardial Ischemia and Glaucoma – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Small Molecules to Inhibit Mst1 for Myocardial Ischemia – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Stem Cell Therapy for Cardiovascular Disease – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
VM-202 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
Myocardial Ischemia – Recent Pipeline Updates 63
Myocardial Ischemia – Dormant Projects 69
Myocardial Ischemia – Product Development Milestones 70
Featured News & Press Releases 70
Jan 27, 2015: Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell & Gene Therapy Forum 70
Sep 03, 2014: Taxus Cardium to Present at the Rodman & Renshaw 16th Annual Global Investment Conference in New York City 72
Aug 13, 2014: Taxus Cardium Announces Biological and Clinical Advances in Angiogenic Gene Therapy for Heart Disease in Journal of Cardiovascular Pharmacology 73
Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention 73
Jan 27, 2014: Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings 74
May 02, 2013: Cardium Therapeutics Announces Publication Of Data On Generx In Journal Molecular Therapy 75
Nov 19, 2012: Cardium Therapeutics Announces Patent Award For Rights To Cardiovascular Gene Therapy For Treatment Of Heart Disease 76
Oct 25, 2012: Cytori Announces Japanese Approval For Clinical Studies Of Cardiovascular And Chronic Liver Disease Cell Therapy 78
May 18, 2012: New drug discovery collaborations with Queen Mary University of London launched 78
Mar 20, 2012: Cardium Therapeutics Initiates Generx Phase III Clinical Registration Study 79
Appendix 81
Methodology 81
Coverage 81
Secondary Research 81
Primary Research 81
Expert Panel Validation 81
Contact Us 81
Disclaimer 82
【レポート販売概要】
■ タイトル：心筋虚血(Myocardial Ischemia)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Myocardial Ischemia - Pipeline Review, H1 2015
■ 発行日：2015年2月24日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6276IDB
■ 調査対象地域：グローバル
- 常温保存可能食品向け包装パッケージの世界市場2015-2019About Ambient Food Packaging Ambient foods are basically stored and retailed at room temperature. They undergo rigorous heat treatment to destroy potentially harmful microorganisms and have a long shelf-life. Pasteurisation and sterilisation are the two primary heat treatment processes used in the packaging of ambient food. The global food and beverages market is expected to reach $5.77 trillion b …
- 吸引＆生検針の世界市場予測（～2024年）“The aspiration and biopsy needles market is projected to grow at a CAGR of 7.3%.” The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019, at a CAGR of 7.3%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimall …
- 腹水(Ascites)：世界の治験レビュー（2015年上半期版）Ascites Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2015" provides data on the Ascites clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ascites. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- UAVフライトトレーニング及びフライトシミュレーションの世界市場About UAV flight simulator A UAV flight simulator is a device that artificially redesigns a flight and various aspects of the flight environment. The flight simulator is used for initial and recurrent training: initial training for new pilots and recurrent training for the existing pilots. A flight simulator covers simulation in three areas: aircraft, environment, and cueing simulation; simulator …
- 世界のタブレットディスプレー市場動向（2012-2016）TechNavio's analysts forecast the Global Tablet Display market to grow at a CAGR of 49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing sales of tablets. The Global Tablet Display market has also been witnessing the declining ASP of tablets. However, the emergence of tablets could pose a challenge to the growth of this market. TechNavio …
- 世界の潜水艦及びMRO市場2015-2025Summary The Global Submarine Market 2015-2025 report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The global Submarine market is expected to be worth US$22.9 b …
- 世界における血液型・分類検査・NAT（核酸増幅検査）機器市場及び主要サプライヤー動向This 68-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, a …
- デジタルフォレンジクスの世界市場：コンピュータフォレンジクス、ネットワークフォレンジクス、モバイルデバイスフォレンジクス、クラウドフォレンジクスThe world is now wholly dependent on digital devices and this space is continuously evolving. Technologies such as cloud and Internet of Things (IoT) are deeply penetrating into the IT space, defining the future of cyber world, making digital information more distributed than ever. This, in turn, is expected to bring huge contribution from various digital forensics vendors to meet the growing dema …
- アジア太平洋の眼科用レンズ＆精密光学製造装置市場Ophthalmic Lens and Precision Optics Manufacturing Machines Market in APAC: About this market Technavio’s ophthalmic lens and precision optics manufacturing machines market analysis considers sales from both ophthalmic lens and precision optics. Our report also provides a detailed analysis of the market in China, Japan, Thailand, The Philippines, and rest of APAC. In 2019, the ophthalmic lens segm …
- 世界の患者モニタリングデバイス/装置/システム市場動向（～2018）Attributed to the Rising Prevalence of Neuro-degenerative Diseases, the Patient Monitoring Market in the Neuromonitoring Segment Will Be the Fastest Growing Segment in the Next Five Years The patient monitoring devices form an indispensible part of medical team for every procedure, whether operating in a small clinic or a large multi-specialty hospital. Advanced technology has reduced the size of …
- ショルダーバッグの世界市場2015-2019About Shoulder Bags Shoulder bags have become the most desirable fashion accessory after shoes and are now considered as status symbols. Consequently, the demand for luxury and premium handbags is gaining popularity as they create an individual identity. Shoulder bag manufacturers are implementing innovative strategies to cater to the changing consumer demography and preferences, such as demand fo …
- 高級デニム製ジーンズの世界市場2016-2020About Premium Denim Jeans The sales of premium denim jeans were mainly from the specialty stores which is a shift from department stores globally. New trends and product innovation in premium range provide prospects for the market growth over the forecast period. Technavio’s analysts forecast the global premium denim jeans market to grow at a CAGR of 8.09% during the period 2016-2020. [Covered in …
- エアコン市場（～2019）：世界市場The expansion of the global air conditioner industry is forecast to reach 4.8% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 8.1%. Currently, self-contained wall and window type air conditioners account for 42.7% of the global demand while the remaining market share is divided between air conditioner parts (34.9%), other air conditioners with …
- インダストリアルIoT（産業向けモノのインターネット）の世界市場予測（～2022年）The IIoT market was valued at USD 113.71 Billion in 2015 and is expected to reach USD 195.47 Billion by 2022, at a CAGR of 7.89% during the forecast period. The factors driving the growth of the IIoT market include technological advancements in semiconductor and electronics industries, the evolution of cloud computing technologies, and need to implement predictive maintenance techniques in industr …
- 血管閉鎖装置（VCD）の世界市場の予測＆動向分析：製品別（アクティブ近似器、縫合ベースデバイス、クリップベースデバイス、受動近似器、コラーゲンプラグ、シーラント/ゲルベースデバイス、圧縮補助デバイス、外部止血デバイス）、エンドユーザー別（急性ケア施設、病院、診療所）、セグメント予測、2013-2024Global vascular closure devices (VCDs) market is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of VCDs for improved patient comfort and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption …
